These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16221232)

  • 41. Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant.
    Desombere I; Van der Wielen M; Van Damme P; Stoffel M; De Clercq N; Goilav C; Leroux-Roels G
    Vaccine; 2002 Jun; 20(19-20):2597-602. PubMed ID: 12057618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients.
    Buti M; Viladomiu L; Jardi R; Olmos A; Rodriguez JA; Bartolome J; Esteban R; Guardia J
    Am J Nephrol; 1992; 12(3):144-7. PubMed ID: 1415374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity and immunization costs of adjuvanted versus non-adjuvanted hepatitis B vaccine in chronic kidney disease patients.
    Vilajeliu A; Sequera VG; García-Basteiro AL; Sicuri E; Aldea M; Velasco C; Bayas JM
    Hum Vaccin Immunother; 2016 Sep; 12(9):2317-21. PubMed ID: 27105182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis.
    Liu YL; Kao MT; Huang CC
    Vaccine; 2005 Jun; 23(30):3957-60. PubMed ID: 15917117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New vaccination protocol against hepatitis B for hemodialysis patients--a single-centre experience].
    Resić H; Kukavica N; Masnić F; Prohić N; Sahović V; Ajanović S; Corić A; Avdić E; Helać-Cvijetić D
    Acta Med Croatica; 2011 Dec; 65(5):405-14. PubMed ID: 22994011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
    Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY
    Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine.
    Kuan RK; Janssen R; Heyward W; Bennett S; Nordyke R
    Vaccine; 2013 Aug; 31(37):4024-32. PubMed ID: 23707166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS/S hepatitis B vaccine Sci-B-Vac™, as compared to Engerix B
    Elhanan E; Boaz M; Schwartz I; Schwartz D; Chernin G; Soetendorp H; Gal Oz A; Agbaria A; Weinstein T
    Clin Exp Nephrol; 2018 Feb; 22(1):151-158. PubMed ID: 28456864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
    Chow KM; Law MC; Leung CB; Szeto CC; Li PK
    Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines.
    Coates T; Wilson R; Patrick G; André F; Watson V
    Clin Ther; 2001 Mar; 23(3):392-403. PubMed ID: 11318074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel perspectives on the hepatitis B virus vaccine in the chronic kidney disease population.
    Fabrizi F; Martin P; Messa P
    Int J Artif Organs; 2015 Dec; 38(12):625-31. PubMed ID: 26821784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H; Dooki MR; Ebrahimnejad MS
    J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules.
    McNulty CA; Bowen JK; Williams AJ
    Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants.
    Lee AW; Vesikari T; Gilbert CL; Klopfer SO; Schödel FP; Bhuyan PK
    Vaccine; 2011 Oct; 29(45):7942-8. PubMed ID: 21875633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination.
    Barraclough KA; Wiggins KJ; Hawley CM; van Eps CL; Mudge DW; Johnson DW; Whitby M; Carpenter S; Playford EG
    Am J Kidney Dis; 2009 Jul; 54(1):95-103. PubMed ID: 19481320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.